Title  | Date  | Price |
|---|
Bigpharma Partnering Agreements
| Mar 2008 |
£1,220 |
Pharmaceutical Distribution in Europe
The Emergence of Direct-to-Pharmacy Supply
| Feb 2008 |
£995 |
Launching Combination Products
Brand Extension and Franchise Development Strategies
| Jan 2008 |
£1,995 |
A Guidebook to Pharma Brand Optimization
Lifecycle Management Strategy
| Jan 2008 |
£3,915 |
Pharmaceutical Product Approval Trends, 2007
Key Market Benchmarks And Strategic Insights
| Dec 2007 |
£1,299 |
Pharmaceutical Sales Force Effectiveness Metrics
Are You Measuring the Wrong Things?
| Nov 2007 |
£495 |
Pharmacies and Drug Retailers in China
| Nov 2007 |
£305 |
Canadian Pharmaceutical Sales Management
| Nov 2007 |
£3,915 |
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
Sales & Marketing
| Oct 2007 |
£3,800 |
Pharmaceutical Medical Publications
Market Preparation & Strategic Support
| Sep 2007 |
£3,915 |
Launch Strategies - Analyzing Market Trends and Regulatory Impacts
| Aug 2007 |
£8,010 |
Bringing Drugs to Market The role of CRM in improving sales & marketing (Review Report)
| Aug 2007 |
£1,000 |
Pharmaceutical Sales Management 2008
| Aug 2007 |
£3,915 |
Online Marketing and eDetailing Europe
| Jul 2007 |
£75 |
Developing Integrated Market Research Functions
Decision Support for 2008
| Jul 2007 |
£3,915 |
Delivering Maximum Brand Impact Via Pharmaceutical Market Analytics
| Jul 2007 |
£1,775 |
Drug Repositioning Strategies
Innovative Strategies To Boost Pipeline Productivity
| Jun 2007 |
£1,495 |
Stakeholder Opinions: Fibromyalgia - Potentially lucrative market soon to become reality
| May 2007 |
£2,000 |
Pharmaceutical Product Relaunch
Preserving Market Share through Line Extension and New Market Entry Strategies
| Apr 2007 |
£3,915 |
Pharmaceutical Customer Relationship Management
Developing and Improving CRM
| Apr 2007 |
£3,915 |
China Medical Sales Channel Report, 2006-2007
| Mar 2007 |
£460 |
Early-Stage Pharmaceutical Marketing Budgets
Preparing for Product Launch
| Mar 2007 |
£3,915 |
Pharma Marketing ROI
| Jan 2007 |
£75 |
Post-Launch Brand Marketing in Select Affiliate Markets
| Jan 2007 |
£1,675 |
US Launch
Phase IIIA, Phase IIIB and Launch Year Brand Commercialization
| Dec 2006 |
£3,915 |
Optimizing Sales Force Effectiveness
From quantity to quality
| Nov 2006 |
£4,000 |
Pharmaceutical Sales Training Groups
Building Better Sales Forces
| Oct 2006 |
£1,675 |
A Product Director's Guide to Promotional Mix
| Sep 2006 |
£1,675 |
Patient Compliance Europe
| Aug 2006 |
£75 |
Pharmaceutical Sales Training: Turning New Hires into Top Performers
| Jun 2006 |
£2,470 |
Sales Force Effectiveness
Benchmarking the Resources and Structure Required to Service the U.S. Hospital Marketplace
| Jun 2006 |
£1,755 |
Sales Force Effectiveness: Benchmarking the Resources and Structure Required to Service the U.S. Hospital Marketplace
| Jun 2006 |
£1,755 |
Blockbuster Pharmaceutical Launches
Establishing Market Leadership
| May 2006 |
£1,675 |
Marketing Mid-Tier Pharmaceutical Brands
Winning Resources for near-Blockbusters
| May 2006 |
£1,675 |
Small & Specialty Drug Branding
Tapping Niche Market Potential
| May 2006 |
£1,675 |
Drug Safety for Marketed Drugs
| Apr 2006 |
£75 |
Marketing ROI for Pharma
| Jan 2006 |
£75 |
Pharmacogenomics: New Technologies
In the Development of Personalized Therapies
| Aug 2005 |
£2,315 |
Global Pharmaceutical Launches
Marketing Budgets and Staffing (Phase 3 to Post-Launch)
| Jan 2005 |
£1,675 |
Medical Affairs Excellence
Structuring, Funding, & Aligning for Global Success
| May 2004 |
£2,405 |
Launching Pharmaceutical Megabrands
Best Practices in Marketing Blockbusters
| Feb 2004 |
£4,055 |
previous
